Gynecologic Cancer Translational Research Center of Excellence (GYN-COE)
Background: According to the American Cancer Society, an estimated 88,000 new cases of gynecologic cancer were expected to be diagnosed in 2012 in the U.S., and over 29,000 American women will lose their battle with this deadly disease. In addition to imposing a significant burden on patients and their families, gynecologic cancer places a significant burden on the health care system. According to the Agency for Healthcare Research and Quality in the Department of Health and Human Services, annual health care costs for gynecologic malignancies are staggering with estimates running in excess of $3 billion dollars annually. Despite improvements in cancer care in the United States, cancer-related morbidities and mortality for advanced and recurrent gynecologic malignancies remain at unacceptable levels. Endometrial cancer has seen a slight increase in both new cancer incidents and annual death rates over the past 30 years.
To address these major issues, several institutions with extensive experience and interest in gynecologic cancer have joined together collaboratively with the Gynecologic Cancer Center of Excellence (GYN-COE) at Walter Reed National Military Medical Center in Bethesda, MD, and the Women's Health Integrated Research Center (WHIRC) at Inova Health System in Annandale, VA.
LTC Chad Hamilton, MD FACOG, Principal Investigator